BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2849362)

  • 1. [Metastatic glucagonoma. Complete remission by dacarbazine (5 years' recession)].
    Jeanmougin M; Civatte J; Bonvalet D; Passa P; Verola O; Zylberait D
    Ann Dermatol Venereol; 1988; 115(8):833-8. PubMed ID: 2849362
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of metastatic glucagonoma with dacarbazine.
    Kurose T; Seino Y; Ishida H; Fujita J; Taminato T; Matsukura M; Imura H
    Lancet; 1984 Mar; 1(8377):621-2. PubMed ID: 6142319
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
    Moattari AR; Cho K; Vinik AI
    Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.
    Schmid R; Allescher HD; Schepp W; Hölscher A; Siewert R; Schusdziarra V; Classen M
    Hepatogastroenterology; 1988 Feb; 35(1):34-7. PubMed ID: 2896149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagonoma and dacarbazine.
    Duncan LA; Marynick SP
    Ann Intern Med; 1982 Dec; 97(6):930. PubMed ID: 6293359
    [No Abstract]   [Full Text] [Related]  

  • 6. Unsuccessful DTIC treatment of a patient with glucagonoma syndrome.
    Hallengren B; Dymling JF; Manhem P; Tennvall L; Tibblin S
    Acta Med Scand; 1983; 213(4):317-8. PubMed ID: 6310975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The glucagonoma syndrome--a not-so-well-known cutaneous paraneoplastic condition. Case report].
    Galle K; Schweiss D
    Hautarzt; 1984 Apr; 35(4):204-9. PubMed ID: 6327570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreduction surgery for metastatic glucagonoma. A clinicopathologic study with special reference to the utility of immunocytochemistry and ultrastructure in diagnosis.
    Rader DL; Martin JK; Scheithauer BW
    Minn Med; 1984 Sep; 67(9):483-5, 516. PubMed ID: 6092886
    [No Abstract]   [Full Text] [Related]  

  • 9. Response of glucagonoma syndrome to lomustine.
    Khandekar JD; Sriratana P
    Cancer Treat Rep; 1986 Mar; 70(3):433-4. PubMed ID: 3006914
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver transplantation for metastatic neuroendocrine tumors.
    Schweizer RT; Alsina AE; Rosson R; Bartus SA
    Transplant Proc; 1993 Apr; 25(2):1973. PubMed ID: 8385828
    [No Abstract]   [Full Text] [Related]  

  • 11. [Glucagonoma syndrome. Unusual histologic image].
    Poiares Baptista A; Tellechea O; Aguiar M; Leitão A
    Ann Dermatol Venereol; 1987; 114(1):55-8. PubMed ID: 3034125
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
    Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
    Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
    Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
    N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
    [No Abstract]   [Full Text] [Related]  

  • 14. Vipoma, glucagonoma and the role of Sandostatin.
    Bloom SR
    NATNEWS; 1989 Jul; 26(7):15. PubMed ID: 2550822
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucagonoma syndrome with normal blood glucagon ].
    Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
    Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant endocrine tumor of the pancreas and ensuing clinical syndromes].
    Boumghar M
    J Chir (Paris); 1988 Mar; 125(3):174-7. PubMed ID: 2836444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.
    van der Loos TL; Lambrecht ER; Lambers JC
    J Am Acad Dermatol; 1987 Feb; 16(2 Pt 2):468-72. PubMed ID: 3029193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant glucagonoma syndrome: response to chemotherapy.
    Marynick SP; Fagadau WR; Duncan LA
    Ann Intern Med; 1980 Sep; 93(3):453-4. PubMed ID: 6254416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pancreatic glucagonoma. Apropos of a case].
    Mathis P; Diebold MD; Servel R
    Chirurgie; 1987; 113(3):258-61. PubMed ID: 2820663
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glucagonoma syndrome].
    Baptista AP; Tellechea O; Aguiar M; Leitão A
    Acta Med Port; 1988; 1(2):141-4. PubMed ID: 2849865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.